Boston Scientific (BSX) jumps as Q4 results exceed analyst expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Boston Scientific (BSX) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
January 31, 2024 6:32 AM ESTBoston Scientific (NYSE: BSX) reported Q4 EPS of $0.55, $0.04 better than the analyst estimate of $0.51. Revenue for the quarter came in at $3.73 billion versus the consensus estimate of $3.6 billion.
The company estimates net sales growth for the full year 2024, versus the prior year period, to be in a range of... More
